Amgen Announces Award for Science Teaching Excellence
Call for Nominations
Nominations Deadline: February 29, 2004
Seattle (January 5, 2004) – Amgen Inc. (NASDAQ:AMGN), the world's largest
biotechnology company, today announced it has begun accepting nominations for the
2004 Amgen Award for Science Teaching Excellence in King and Snohomish counties,
the company's recognition program for science education. Two K-12 educators who
work in either public or private schools in those two counties will each receive an
unrestricted $10,000 award from Amgen, and will be honored at an award dinner in
May.
For 12 years, Amgen has conducted a teaching award program, and recently modified
the award to focus solely on excellence in science teaching. This will be the second
year the Amgen Award for Science Teaching Excellence has been conducted in
Washington and is directed toward teachers in King and Snohomish counties. Amgen
also conducts similar programs in California; Colorado; Louisville, Kentucky; Boston and
Cambridge, Massachusetts; Puerto Rico; and Rhode Island.
Anyone can nominate an educator who teaches science. The nomination letter should
include: the full name of the teacher; the name and address of the school; the name of
the school district; the school's phone number; the grade level taught by the science
teacher; the nominator's relationship to the science teacher; the nominator's phone
number; and a description of why the science teacher deserves the award. The letter
should describe the teacher's attributes in the areas of creativity, teaching effectiveness,
best practice development, and instructional and motivational ability.
Letters should be sent to: Amgen's Award for Science Teaching Excellence, Amgen
Washington, Attn: Janis Wignall, 51 University Street, Seattle, WA 98101. Nominations
can also be submitted electronically, at www.Amgen.com/ScienceTeacherAward/.
Nominations for the award will be accepted immediately, through February 29,
2004.
Amgen Announces Award for Science Teaching Excellence
Amgen is a leading global biotechnology company that discovers, develops,
manufactures and markets important human therapeutics based on advances in cellular
and molecular biology.
CONTACT: Kristin Wennberg (206) 265-4061
Amgen, Corporate Communications
EDITORS NOTE: An electronic version of this news release may be accessed via our
Web site at www.amgen.com. Journalists and media representatives may sign up to
receive all news releases electronically at the time of announcement by filling out a
short form in the Media section of the Web site.